ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B

Journal of Clinical Virology

Volumn 42, Issue 2, 2008, Pages 160-164

  ter Borg, M J ^a   Hansen, B E ^a   Bigot, G ^a   Haagmans, B L ^a   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ALT; Chronic hepatitis B; HBeAg positive; HBV DNA

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; PEGINTERFERON ALPHA2B; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS B; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD;

EID: 44149127186     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.02.007     Document Type: Article

References (16)

1. Alexander G.J., Brahm J., Fagan E.A., Smith H.M., Daniels H.M., Eddleston A.L., et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 2 8550 (1987) 66-69
2. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 10 (1988) 1942-1956
3. Flink H.J., Sprengers D., Hansen B.E., van Zonneveld M., de Man R.A., Schalm S.W., et al. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy. Gut 54 11 (2005) 1604-1609
4. Heermann K.H., Gerlich W.H., Chudy M., Schaefer S., and Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 37 1 (1999) 68-73
5. Honkoop P., de Man R.A., Niesters H.G., Zondervan P.E., and Schalm S.W. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology 32 3 (2000) 635-639
6. Janssen H.L., van Zonneveld M., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365 9454 (2005) 123-129
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11 2 (2004) 97-107
8. Nair S., and Perrillo R.P. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?. Hepatology 34 5 (2001) 1021-1026
9. Pas S.D., Fries E., De Man R.A., Osterhaus A.D., and Niesters H.G. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 38 8 (2000) 2897-2901
10. Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 120 4 (2001) 1009-1022
11. Perrillo R.P., Schiff E.R., Davis G.L., Bodenheimer Jr. H.C., Lindsay K., Payne J., et al., The Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323 5 (1990) 295-301
12. Peters M., Davis G.L., Dooley J.S., and Hoofnagle J.H. The interferon system in acute and chronic viral hepatitis. Prog Liver Dis 8 (1986) 453-467
13. Sprengers D., and Janssen H.L. Immunomodulatory therapy for chronic hepatitis B virus infection. Fundam Clin Pharmacol 19 1 (2005) 17-26
14. Tang T.J., Kwekkeboom J., Laman J.D., Niesters H.G., Zondervan P.E., de Man R.A., et al. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J Viral Hepat 10 3 (2003) 159-167
15. ter Borg M.J., van Zonneveld M., Zeuzem S., Senturk H., Akarca U.S., Simon C., et al. Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response. Hepatology 44 3 (2006) 721-727
16. Thiebaut R., Jacqmin-Gadda H., Chene G., Leport C., and Commenges D. Bivariate linear mixed models using SAS proc MIXED. Comput. Methods Prog. Biomed. 69 3 (2002) 249-256